Else Nutrition Holdings Inc. has seen a notable decline in its stock performance recently, with a significant drop this week.
Else Nutrition Holdings Inc. (CSE: BABY) experienced a challenging week, with its stock price down 11.11% over the last five trading days. While the company reported promising operational improvements and financial results for fiscal year 2025, market sentiment appears to be cautious, contributing to the stock's downward trajectory.
Investor takeaway: Investors may want to consider the operational advancements and potential market growth for Else Nutrition, balanced against the current market performance and overall volatility.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Else Nutrition Holdings Inc
BABY.TO
BABY.TO
Else Nutrition Holdings Inc
WealthAwesomeMarket cap
$1.15M
52W high
$0.25
52W low
$0.01
1W change
+0.00%
Beta
0.97
Analyst Price Targets
Based on analyst covering BABY
Wall Street analysts forecast BABY stock price to rise 24900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.00
+24900.0% Upside
Current Price
C$0.02
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BABY's historical volatility
30-Day Vol
183.7%
Annualized
90-Day Vol
178.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 โ C$0.04 |
| 60 trading days | C$0.02 | C$0.01 โ C$0.04 |
| 90 trading days | C$0.02 | C$0.01 โ C$0.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Stock down 80% YTD amid operational improvements.
Else Nutrition reported a revenue of approximately $6 million for fiscal year 2025, indicating challenges in scaling operations despite achieving a gross profit margin of 34% in Q3 2025.
Bull case
The company has made strides in its operations, achieving a gross profit margin of 34% in Q3 2025, a significant turnaround from previous negative margins. Additionally, the FDA's regulatory progress on infant formula protein standards could strengthen the company's position in the market.
Bear case
Despite these operational improvements, the stock has dropped 80% year-to-date, raising concerns about the company's financial stability and the effectiveness of its growth strategies in a competitive market.
Recent Price Action
Else Nutrition Holdings Inc. closed at C$0.11, with a daily change of 0.00%. Over the past week, the stock has declined by 11.11%, reflecting investor concerns despite the company's recent operational improvements.
Company News and Web Headlines
Recent headlines highlight Else Nutrition's fiscal year 2025 financial results, reporting approximately $6 million in revenue and a gross profit margin improvement to 34% in Q3 2025. The company also exceeded one million cans sold, indicating strong market acceptance. Furthermore, regulatory progress with the FDA on infant formula protein standards could benefit its growth in the infant nutrition segment.
Technical Picture
The technical indicators for Else Nutrition show a last close of C$0.11, significantly above its 50-day moving average of C$0.03 and its 200-day moving average of C$0.09. The stock has a 52-week range of C$0.01 to C$0.25, currently trading at 40% of this range. The stock's beta of 0.97 suggests it moves in line with market volatility. However, the trading volume has been notably low at 2,520 shares, compared to the 20-day average volume of 169,200 shares.
Advertisement
